Michael K. Green

Acordia, Inc. provides insurance brokerage and risk management consulting services. The company offers property and casualty coverage include specialty coverage for professionals in the construction, entertainment, health care, transportation industries, life, health products for individuals and groups. Acordia was founded in 1989 and is headquartered in Chicago, IL.

Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL.

Rocket Software, Inc. engages in the development of software products for corporations, government agencies, and other organizations. It offers Rocket Aldon, Rocket BlueZone ,Rocket LegaSuite, Rocket MultiValue Integration Server, Rocket TRUfusion Enterprise, Rocket UniVErse, Rocket API, Rocket D3, Rocket iCluster, Rocket Servergraph, Rocket UniData, and Rocket z/Trim. The company was founded by Andrew J. Youniss on April 16, 1990 and is headquartered in Waltham, MA.

MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom.

Health Dialog Services Corp. provides care management, disease management and analytic services. The firm helps physician groups, health plans and self-insured employers improve healthcare quality while reducing overall costs. The firm's services include analytic services and telephonic and other care management support for individuals. It helps individuals become more actively engaged in their healthcare and have more effective relationships with their physicians. The company was founded by George Bennett and Chris McKown in 1997 and is headquartered in Boston, MA.

Augment Securities, Inc. (Augment Securities) is a venture capital firm, a subsidiary of Spencer Trask & Co. founded in 1991 by Kevin Brian Kimberlin. The firm is headquartered in New York.

PharmaIN Corp. develops affinity-based drug delivery solutions for biotech and pharmaceutical applications. It develops drug therapies using its proprietary, novel drug delivery platform called Protected Graft Co-polymer. The company was founded by Elijah M. Bolotin in 2000 and is headquartered in Bothell, WA.

Pinnacle Biologics, Inc. specializes in revitalizing healthcare therapies by developing approaches to the global commercialization of products. It engages in assisting pharmaceutical and biotech companies in providing full portfolio of services aimed at the commercialization or continuation. The company was founded by Viren Grover, Guillermo A. Herrera and James R. Miller in 2007 and is headquartered in Chicago, IL.

Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA.

Maternity Neighborhood, Inc. develops digital tools to support woman-centered and relationship-based maternity care. It offers clinical care, patient engagement, health record, billing and MCH programs. The company was founded by Ron Duplain, Michael Davis and Brynne Potter in 2010 and is headquartered in Charlottesville, VA.

Kidd & Co. LLC (Kidd) is a private equity firm founded in 1976 by William J. Kidd. The firm is headquartered in Old Greenwich, Connecticut.

Part of Tango Private Holdings II, LLC, Covad Communications International BV provides high-speed digital communications services using digital subscriber line technology.

Part of UBS Group AG, Kidder Peabody & Co., Inc. /Non Retail Unit/ is a security brokers & dealers. The company is based in Staten Island, NY.

University of Akron provides public research education. Its programs include under graduate studies, graduate studies, international studies, law, and continuing education. The company was founded in 1870 and is headquartered in Akron, OH.

Orchestra Medical Ventures LLC (Orchestra Medical Ventures) is a venture capital firm founded in 2001 by Richard P. Geoffrion and Yuval Binur. The firm is headquartered in New Hope, Pennsylvania.

African Wildlife Foundation, Inc. operates an international conservation organization focused on the African continent. The organization programs and conservation strategies are based on science and designed to protect both the wild lands and wildlife of Africa. The organization was founded in 1961 and is headquartered in Washington, DC.

Illinois Ventures LLC (Illinois Ventures) is a venture capital firm founded in 2000. The firm is headquartered in Champaign, Illinois.

Motus G.I. Medical Technologies Ltd. develops a system for diagnosis and treatment of large intestine diseases. The company was founded by Boris Shtul on October 6, 2008 and is headquartered in Tirat Carmel, Israel.

Part of Orchestra Biomed Holdings, Inc., FreeHold Surgical LLC is a company that specializes in surgical retractors. The company is based in New Hope, PA. The company's retractors are the only fully and continuously adjustable, completely intracorporeal retractors designed for hands-free tissue retraction. The company was founded by David P. Hochman.

Adgero Biopharmaceuticals Holdings, Inc. a biopharmaceutical company. It focuses on the development of photodynamic therapy for the treatment of rare, unmet medical needs, with particular emphasis on orphan cancer indications. The firm offers candidate, REM-001 therapy, consists of three parts, a laser light source, a light delivery device and the drug REM-001. The company is headquartered inv Princeton, NJ.

Orchestra BioMed, Inc. develops therapies for cardiovascular diseases. The firm offers BackBeat CNT and Virtue SEB. The company was founded in 2017 and is headquartered in New Hope, PA.

Oncolyze, Inc. is a private company developing a novel technology for cancer treatment. The company is based in New York, NY and was founded by Steven J. Evans and John H. Abeles. The company's lead drug candidate targets the cancer cell membrane and selectively kills cancer cells and cancer stem cells while sparing normal cells, potentially providing a highly effective treatment with little to no side effects. The initial therapeutic target is acute myeloid leukemia (AML), a cancer with a low five-year survival rate. Oncolyze's drug has been shown to destroy leukemic cancer stem cells, disrupting current medical treatment. Steven J. Evans has been the CEO since incorporation.